GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Gross PPE

ANL (Adlai Nortye) Other Gross PPE : $2.88 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Other Gross PPE?

Adlai Nortye's Other Gross PPE for the quarter that ended in Jun. 2024 was $2.88 Mil.

Adlai Nortye's quarterly Other Gross PPE increased from Jun. 2023 ($2.72 Mil) to Dec. 2023 ($2.75 Mil) and increased from Dec. 2023 ($2.75 Mil) to Jun. 2024 ($2.88 Mil).

Adlai Nortye's annual Other Gross PPE increased from Dec. 2021 ($2.28 Mil) to Dec. 2022 ($2.81 Mil) but then declined from Dec. 2022 ($2.81 Mil) to Dec. 2023 ($2.75 Mil).

Adlai Nortye Other Gross PPE Historical Data

The historical data trend for Adlai Nortye's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Other Gross PPE Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Other Gross PPE
2.28 2.81 2.75

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Other Gross PPE Get a 7-Day Free Trial 2.81 2.85 2.72 2.75 2.88

Adlai Nortye Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Adlai Nortye Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Gross PPE
Comparable Companies
ABOS IVVD CLSD MNOV AVTE ACRV NTRB EPIX IGMS DOMH VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N2U0:Germany
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Website
https://www.adlainortye.com
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.